Toll-like receptor 4 activation in Barrett’s esophagus results in a strong increase in COX-2 expression
- First Online:
- Cite this article as:
- Verbeek, R.E., Siersema, P.D., Ten Kate, F.J. et al. J Gastroenterol (2014) 49: 1121. doi:10.1007/s00535-013-0862-6
Barrett’s esophagus (BE) is known to progress to esophageal adenocarcinoma in a setting of chronic inflammation. Toll-like receptor (TLR) 4 has been linked to inflammation-associated carcinogenesis. We aimed to determine the expression and functional activity of TLR4 in the esophagus and whether TLR4 activation in BE could promote carcinogenesis by inducing COX-2 expression.
TLR4 expression in esophageal adenocarcinoma, BE, duodenum, reflux esophagitis and normal squamous esophagus biopsies was assessed using real-time PCR and validated by in situ hybridization and immunohistochemistry. Ex vivo cultures of BE, duodenum and normal squamous esophagus biopsies and a BE cell line (BAR-T) were stimulated with the TLR4 agonist lipopolysaccharide (LPS). To evaluate the effect of TLR4 activation, NF-κB activation, IL8 secretion and expression and COX-2 expression were determined.
TLR4 expression was significantly increased in esophageal adenocarcinoma, BE, duodenum and reflux esophagitis compared to normal squamous esophagus. LPS stimulation resulted in NF-κB activation and a dose-dependent increase of IL8 secretion and mRNA expression. The induction of IL8 was more evident in BE compared to normal squamous esophagus. Upon LPS stimulation, COX-2 expression increased significantly in ex vivo cultured BE biopsies, which was observed in both epithelium and lamina propria cells. However, no effect was found in duodenum and normal squamous esophagus biopsies.
TLR4 activation in BE results in a strong increase in COX-2 and may contribute to malignant transformation.
KeywordsBarrett’s esophagus Toll-like receptor 4 Cyclooxygenase-2 Esophageal adenocarcinoma
Enzyme-linked immunosorbent assay
In situ hybridization
Fetal bovin serum
Inflammatory bowel diseases
Mitogen-activated protein kinases
Mitogen- and stress-activated protein kinase
Phosphate buffered saline
Proton pump inhibitors
Quantitative reverse transcriptase polymerase chain reaction
Normal squamous esophagus
Tumor necrosis factor alpha
Toll interacting protein